With a unique footprint of 33 sites in France, including 22 industrial sites and approximately 25,000 employees, Sanofi represents a quarter of the workforce of the entire French pharmaceutical industry.With 16,000 employees and an international network of 12 industrial sites dedicated to vaccine manufacturing, including three in France (Marcy-l'Etoile, Neuville sur Saône, Val-de-Reuil), Sanofi Pasteur’s vaccines protect more than half a billion people in the world.Since the beginning of the pandemic, Sanofi has played a leading role in the fight against COVID-19. Sanofi has invested €3 billion in its French production sites over the past five years, including €1.5 billion to accelerate the build-up of biotechnologies in the country. EVF is a new type of factory designed around a central unit housing several fully digital production modules that make it possible to produce three to four vaccines simultaneously, versus only one in current industrial sites. Sanofi expresses its gratitude to the Auvergne-Rhône-Alpes French region for its support in this project.Sanofi is France’s leading private R&D investor, with more than €2 billion spent each year researching new treatments for patients, totaling half of the private research effort in France.
While you don't need to check your immunization schedule as often, vaccines are an important part of everyday health.© Sanofi 2004-2020 - All rights reservedThis website uses cookies to track its audience and improve its content. Sanofi offers a portfolio of vaccines to protect children, adolescents, and adults from diseases such as influenza, infectious diseases, and endemic diseases. Sanofi, with its global vaccine entity Sanofi Pasteur, is a leading vaccine developer and manufacturer. Sanofi SA (NYSE: SNY) is a multinational pharmaceutical company headquartered in Gentilly, France.
This modularity will make it possible to prioritize the production of a specific vaccine in a more timely manner based on public health issues.Sanofi plays a major role in meeting the health needs of patients and supporting their healthcare. Sanofi offers a portfolio of vaccines to protect children, adolescents, and adults from diseases such as influenza, infectious diseases, and endemic diseases.Sanofi shares the French authorities’ vision for a sovereign Europe in healthcare and announced last February the creation of a new industry-leading European company to provide active pharmaceutical ingredients. At Sanofi Pasteur, we are at the forefront of vaccine research and development, creating immunological solutions to prevent and cure diseases for every stage of life. In collaboration with health authorities and international partners, Sanofi is one of the only companies in the world to work on the search for COVID-19 vaccine candidates by exploring two different technological approaches.Sanofi is also committed to making its vaccine accessible to all and around the world.This website uses cookies to track its audience and improve its content.